About EFPIA
EFPIA is a company based in Belgium. It operates as a Professional Services. EFPIA offers products and services including Pharmaceutical Advocacy and Research Collaboration.
- Latest Funding Round$317.18K (USD), Grant
Jan 2024
- Investors
Products & Services of EFPIA
EFPIA offers a comprehensive portfolio of products and services, including Pharmaceutical Advocacy and Research Collaboration.
Advocacy for pharmaceutical innovation is provided to stakeholders.
Collaboration on medical research is facilitated for industry partners.
Apps and channels of EFPIA
its YouTube channel EFPIA has 1.3K subscribers and 30 videos.
Videos from EFPIA
The most watched videos on EFPIA's YouTube channel, EFPIA (1.3K subscribers). Click a video to play it here.
More on EFPIA.
Funding Insights of EFPIA
- Total Rounds 1
- Last Round Grant — $317,181
- First Round $317,181
(Jan 2024)
- Investors Count 1
All 1 funding rounds of EFPIA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $317,181 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in EFPIA
EFPIA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for EFPIA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EFPIA
31 people are tracked at EFPIA (11 in leadership, 20 in team).
| Name | Role | Group |
|---|---|---|
Joe Jimenez | President | Leadership |
Magda Chlebus | Executive Director Science Policy And Regulatory Affairs | Leadership |
Anna Czwarno | Director, Regulatory & Science, Vaccine Europe At Efpia | Leadership |
Kirsty Reid | Director Science Policy | Leadership |
Andy Powrie-Smith | Executive Director Of Communications & Partnerships | Leadership |
Giulia Biasi | Director Of Communications | Leadership |
Nicolas Creff | Associate Director Research Partnerships | Leadership |
Katarina Nedog | Director Regulatory Policy | Leadership |
Giacomo Borgo | Associate Director Public Affairs | Leadership |
Jyothsna Krishnan | Director, Regulatory, Drug Development & Manufacturing | Leadership |
Michael Swita | Director, Intellectual Property Policy | Leadership |
Martina D'Amore | Manager - Public Affairs | Team |
Christine Fletcher | Efpia Clinical Research Expert Group Representative For GSK | Team |
Aleksandra O. | Regulatory & Scientific Manager | Team |
Tatiana Kirpichenok | Science Policy & Regulatory Business Support Coordinator | Team |
Richard Weaver | Preclinical Development Expert Group, Efpia | Team |
Faraz Kermani | Communications Manager External Affairs | Team |
Polina Zoteva | Communications Lead, Vaccines Europe | Team |
Elaine Towell | Media And Communications Lead | Team |
Lavinia Meloni | Senior Manager Communications | Team |
11 more people are available in the full profile.
Complete people profiles for EFPIA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of EFPIA
The website of EFPIA (efpia.eu) receives about 89.3K visits a month and ranks #445,999 among all websites worldwide, #413 in Biotechnology and Pharmaceuticals.
- Monthly visits89.3K
▼ 5.9% vs previous month
- Unique visitors39.5K
per month
- Global rank#445,999
among all websites
- Category rank#413
Health · Biotechnology and Pharmaceuticals
- Bounce rate47%
- Pages per visit1.6
- Average visit36 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with EFPIA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ifpma.org | 100% | – | #875,178 | View details | |
| phrma.org | 86% | 63.3K | #555,565 | View details | |
egagenerics.com | egagenerics.com | 85% | – | – | – |
icer.org | icer.org | 66% | – | #732,386 | – |
pharma.be | pharma.be | 64% | – | #3,157,088 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for EFPIA
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to EFPIA
10 companies that operate in the same segment as EFPIA (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EFPIA
EFPIA is headquartered in Belgium.
EFPIA is involved in representing the pharmaceutical industry across Europe. Focus is placed on fostering innovation, improving access to medicines, and addressing unmet medical needs. Activities are centered around collaboration with EU leaders, patient organizations, and healthcare professionals. Sectors covered include digital health, precision medicine, and antimicrobial resistance. Solutions are developed through public-private partnerships and responsible innovation practices. Efforts are made to influence pharmaceutical legislation and ensure ethical relationships through the EFPIA Code of Practice.
EFPIA offers Pharmaceutical Advocacy and Research Collaboration.
EFPIA has 1 investor. Key investors include European Union.
EFPIA operates through European Federation Of Pharmaceutical Industries And Associations.